C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/08 (2006.01) A61K 39/155 (2006.01) C07K 14/135 (2006.01)
Patent
CA 2742086
The present invention features live, attenuated respiratory syncytial viruses (RSV) useful as vaccines against RSV infection and/or the development of severe RSV-associated illnesses. The disclosed viruses are attenuated to the extent of being nonpathogenic when administered to a subject but substantially retain the antigenic and immunogenic properties of wild-type RSV.
L'invention concerne un virus syncytial respiratoire (VSR) vivant atténué utile contre les infections par le VSR et/ou le développement de syndromes aigus associés au VSR. Ledit virus, atténué jusqu'à devenir non pathogène lorsqu'administré à un sujet, conserve néanmoins les propriétés antigènes et immunogènes du VSR de type sauvage.
Citron Michael P.
Distefano Daniel J.
Krah David L.
Liang Xiaoping
Yagodich Mary K.
Gowling Lafleur Henderson Llp
Merck Sharp & Dohme Corp.
LandOfFree
Live, attentuated respiratory syncytial virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Live, attentuated respiratory syncytial virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Live, attentuated respiratory syncytial virus will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1470119